Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Clinical Chemistry|November 2, 2019
Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial ImmunotherapySelena Y Lin, Shu-Ching Chang, Stella Lam, et al.
International Journal of Cancer|July 12, 2018
The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cellsSivan Izraely, Shlomit Ben-Menachem, Orit Sagi-Assif, et al.
Scientific Reports|September 23, 2018
Humanin Prevents Age-Related Cognitive Decline in Mice and is Associated with Improved Cognitive Age in HumansKelvin Yen, Junxiang Wan, Hemal H Mehta, et al.
BMC Genomics|March 5, 2016
GWASeq: targeted re-sequencing follow up to GWASMatthew P Salomon, Wai Lok Sibon Li, Christopher K Edlund, et al.
Oncotarget|March 2, 2018
Distinct histone modifications denote early stress-induced drug tolerance in cancerAbdullah Al Emran, Diego M Marzese, Dinoop Ravindran Menon, et al.
Nature Communications|November 8, 2018
Epigenetic profiling for the molecular classification of metastatic brain tumorsJavier I J Orozco, Theo A Knijnenburg, Ayla O Manughian-Peter, et al.
Molecular Cancer|November 29, 2023
Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumorsPere Llinàs-Arias, Miquel Ensenyat-Mendez, Sandra Íñiguez-Muñoz, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
PFHpA alters lipid metabolism and increases the risk of metabolic dysfunction-associated steatotic liver disease in youth-a translational research frameworkBrittney O Baumert, Ana C Maretti-Mira, Zhenjiang Li, et al.
Communications Medicine|October 30, 2025
Translational framework linking perfluoroheptanoic acid (PFHpA) exposure to metabolic dysfunction associated steatotic liver disease in adolescentsBrittney O Baumert, Ana C Maretti-Mira, Douglas I Walker, et al.
Research Square|March 17, 2025
Integrated Spheroid-to-Population Framework for Evaluating PFHpA-Associated Metabolic Dysfunction and Steatotic Liver DiseaseBrittney O Baumert, Ana C Maretti-Mira, Douglas I Walker, et al.
Pageof 6